Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | POLA1 | P09884 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19784709 | 1.00 | TSHR (0.56) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL23191367 | 1.00 | TSHR (0.56) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL25702220 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL1403393 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL30200780 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL19963063 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL19963067 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL1403149 | 0.86 | TSHR (0.54) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL19402824 | 0.83 | TSHR (0.56) | TSHRLMNAALDH1A1KAT2BKMT2A | |
| SCHEMBL19784710 | 0.82 | TSHR (0.57) | TSHRLMNAALDH1A1KAT2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192731-A1 | PROCESS FOR THE STEPWISE SYNTHESIS OF SILAHYDROCARBONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192731-A1 | PROCESS FOR THE STEPWISE SYNTHESIS OF SILAHYDROCARBONS | CCR4, SALL4, CCR2 | TSHR 4142/4885LMNA 3546/4885ALDH1A1 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.